Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Sep;60(3):563–570. doi: 10.1172/JCI108808

Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man.

S B Heymsfield, R A Bethel, E C Hall, J B Mills, M H Moseley, J L Kostyo, D Rudman
PMCID: PMC372401  PMID: 142777

Abstract

Six children aged 12-15 yr, deficient in endogenous growth hormone, were each treated, after a 7-day control period, for 7 days with 0.0168, 0.052, and 0.168 U/kg body wt3/4 human growth (hGH) (doses A, B, and C, respectively) in separate metabolic balance studies. Doses B and C caused a dose-related retention of N, P, K, Na, and Cl in ratios of 1/0.069/4.5/7.5/5.6. These ratios indicate increments in masses of protoplasm/extracellular fluid (ECF)/bone in ratios of 1/2.0/ less than 0.001. Three of the children were also treated with doses A, B, and C of reduced and carbamidomethylated hGH (RCAM-hGH). Doses B and C caused 1.2-2.8 times as much retention of N, P, and K, and 0.3-0.5 times as much retention of Na and Cl, as did the corresponding doses of hGH. The plasmin digest of RCAM-hGH gave results generally similar to RCAM-hGH. For RCAM-hGH and its plasmin digest, N, P, K, Na, and Cl were retained in ratios of about 1/0.14/5.4/2.2/2.1, indicating increments of protoplasm/ECF/bone of about 1/0.8/0.05. These findings indicate that reduction and carbamidomethylation alter the anabolic actions of hGH in man in both quantitative and qualitative manner. RCAM-hGH is more potent in stimulating enlargement of protoplasm and bone, and less potent in stimulating expansion of ECF, than is the native hormone. The profile of anabolic actions of RCAM-hGH in man does not appear to be further altered by digestion with plasmin.

Full text

PDF
563

Images in this article

564Image
on p.564

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bewley T. A., Brovetto-Cruz J., Li C. H. Human pituitary growth hormone. Physicochemical investigations of the native and reduced-alkylated protein. Biochemistry. 1969 Dec;8(12):4701–4708. doi: 10.1021/bi00840a007. [DOI] [PubMed] [Google Scholar]
  2. Cerosi E., Li C. H., Luft R. Some metabolic changes induced by acute administration of native and reduced-tetra-S-carbamidomethylated human growth hormone in man. J Clin Endocrinol Metab. 1972 Apr;34(4):644–649. doi: 10.1210/jcem-34-4-644. [DOI] [PubMed] [Google Scholar]
  3. Chrambach A., Yadley R. A., Ben-David M., Rodbard D. Isohormones of human growth hormone. I. Characterization by electrophoresis and isoelectric focusing in polyacrylamide gel. Endocrinology. 1973 Oct;93(4):848–857. doi: 10.1210/endo-93-4-848. [DOI] [PubMed] [Google Scholar]
  4. Connors M. H., Kaplan S. L., Li C. H., Grumbach M. M. Retention of biologic activity of human growth hormone in man after reduction and alkylation. J Clin Endocrinol Metab. 1973 Oct;37(4):499–504. doi: 10.1210/jcem-37-4-499. [DOI] [PubMed] [Google Scholar]
  5. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  6. HENNEMAN D. H., HENNEMAN P. H. Effects of human growth hormone on levels of blood urinary carbohydrate and fat metabolites in man. J Clin Invest. 1960 Aug;39:1239–1245. doi: 10.1172/JCI104139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kostyo J. L., Wilhelmi A. F. Conference on the structure-function relationships of pituitary growth hormone: a report. Metabolism. 1976 Jan;25(1):105–124. doi: 10.1016/0026-0495(76)90165-7. [DOI] [PubMed] [Google Scholar]
  8. Mills J. B., Ashworth R. B., Wilhelmi A. E., Hartree A. S. Improved method for the extraction and purification of human growth hormone. J Clin Endocrinol Metab. 1969 Nov;29(11):1456–1459. doi: 10.1210/jcem-29-11-1456. [DOI] [PubMed] [Google Scholar]
  9. Mills J. B., Reagan C. R., Rudman D., Kostyo J. L., Zachariah P., Wilhelmi A. E. Metabolic effects of plasmin digests of human growth hormone in the rat and man. J Clin Invest. 1973 Nov;52(11):2941–2951. doi: 10.1172/JCI107491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Parlow A. F., Wilhelmi A. E., Reichert L. E., Jr Further studies on the fractionation of human pituitary glands. Endocrinology. 1965 Dec;77(6):1126–1134. doi: 10.1210/endo-77-6-1126. [DOI] [PubMed] [Google Scholar]
  11. Reagan C. R., Mills J. B., Kostyo J. L., Wilhelmi A. E. Biological properties of plasmin digests of S-carbamidomethylated human growth hormone. Proc Natl Acad Sci U S A. 1975 May;72(5):1684–1686. doi: 10.1073/pnas.72.5.1684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rudman D., Chyatte S. B., Patterson J. H., Gerron G. G., O'Beirne I., Barlow J., Ahmann P., Jordan A., Mosteller R. C. Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy. J Clin Invest. 1971 Sep;50(9):1941–1949. doi: 10.1172/JCI106686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SCHALCH D. S., PARKER M. L. A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA. Nature. 1964 Sep 12;203:1141–1142. doi: 10.1038/2031141a0. [DOI] [PubMed] [Google Scholar]
  14. Singh R. N., Seavey B. K., Rice V. P., Lindsey T. T., Lewis U. J. Modified forms of human growth hormone with increased biological activities. Endocrinology. 1974 Mar;94(3):883–891. doi: 10.1210/endo-94-3-883. [DOI] [PubMed] [Google Scholar]
  15. Taylor A. L., Finster J. L., Mintz D. H. Metabolic clearance and production rates of human growth hormone. J Clin Invest. 1969 Dec;48(12):2349–2358. doi: 10.1172/JCI106201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vávra I., Machová A., Holecek V., Cort J. H., Zaoral M., Sorm F. Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet. 1968 May 4;1(7549):948–952. doi: 10.1016/s0140-6736(68)90904-5. [DOI] [PubMed] [Google Scholar]
  17. Yadley R. A., Chrambach A. Isohormones of human growth hormone. II. Plasmin-catalyzed transformation and increase in prolactin biological activity. Endocrinology. 1973 Oct;93(4):858–865. doi: 10.1210/endo-93-4-858. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES